Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Tyson & Blake is a private investment firm founded in Luxembourg, focusing on growth-stage companies in the HealthTech/Digital Health and FinTech sectors. Established to provide both capital and strategic advisory services, the firm operates globally, engaging deeply with its portfolio companies to drive sustainable growth and measurable outcomes. Tyson & Blake positions itself as an 'active owner,' emphasizing hands-on involvement in the operational aspects of its investments.
The firm has developed a dual-mandate model that combines investment and advisory services, allowing it to support companies not only with funding but also with expertise in mergers and acquisitions, equity and debt financing, and specialized crypto advisory. This comprehensive approach enables Tyson & Blake to create long-term value for both its portfolio companies and the communities they serve.
Currently, Tyson & Blake manages a portfolio that includes notable companies across various geographies, including Finland and Australia. The firm continues to seek out innovative businesses that leverage transformative technologies, particularly artificial intelligence, to address pressing challenges in healthcare and financial services.
Tyson & Blake invests primarily in growth-stage companies within the HealthTech/Digital Health and FinTech sectors. The firm seeks to partner with businesses that utilize transformative technologies, especially artificial intelligence, to develop innovative solutions. Their investment strategy emphasizes identifying companies with strong growth potential and measurable outcomes, aiming to create long-term value for both the companies and the communities they serve.
The firm operates globally, allowing it to tap into diverse markets and opportunities. Tyson & Blake's check sizes typically align with growth equity investments, although specific figures are not disclosed. The firm prefers to engage as an operator-investor, providing hands-on support and strategic advisory services to its portfolio companies. This includes assistance with mergers and acquisitions, equity and debt financing, and specialized crypto advisory, ensuring that their investments are not just financial but also operationally impactful.
Tyson & Blake's portfolio includes several notable companies that exemplify its focus on HealthTech and FinTech:
These companies reflect Tyson & Blake's commitment to investing in innovative solutions that leverage technology to address significant challenges in their respective sectors.
Carl Christopher Tornblom: Partner, Founder & Chairman. Tornblom has extensive experience in private equity and venture capital, having led numerous successful investments in the HealthTech and FinTech sectors.
Peter Almberg: Partner, Founder and Chairman of Katalysen Ventures AB. Almberg brings a wealth of knowledge in strategic advisory and investment management, with a focus on technology-driven companies.
Aaron Michelin: Partner, Founder and Chairman of Corporatum Oy. Michelin has a strong background in operational management and investment strategy, particularly in growth-stage technology companies.
To pitch Tyson & Blake, founders should visit their website at tysonblake.com. It is recommended to include a comprehensive deck that outlines the business model, market analysis, and growth strategy. The firm prefers warm introductions but accepts direct submissions through their website.
Response times may vary, but founders can expect to hear back within a few weeks. Providing detailed information upfront can facilitate a quicker review process.
In January 2022, Tyson & Blake announced a lead investment in StrongRoom AI, an Australian healthcare AI company, further expanding its healthcare portfolio.
In 2017, Tyson & Blake made a lead investment in The Mealplanner Technologies, a Finnish startup focused on diet management for chronic disease patients, as part of a €1M seed round.
What are Tyson & Blake's investment criteria?
Tyson & Blake focuses on growth-stage companies in the HealthTech/Digital Health and FinTech sectors. They seek businesses that leverage transformative technologies, particularly artificial intelligence, to create innovative solutions with strong growth potential.
How can I pitch to Tyson & Blake?
Founders can submit their pitches through the firm's website at tysonblake.com. It is advisable to include detailed information about the business model, market opportunity, and how the technology addresses specific challenges.
What makes Tyson & Blake different from other investors?
Tyson & Blake operates as an 'active owner,' providing not only capital but also strategic advisory services. This includes M&A advisory, equity and debt financing, and specialized crypto advisory, ensuring a hands-on approach to driving growth.
What is the geographic scope of Tyson & Blake's investments?
The firm operates globally, with investments in companies located in various regions, including Europe and Australia. This broad geographic focus allows them to tap into diverse markets and opportunities.
What is the typical check size for Tyson & Blake?
While specific check sizes are not disclosed, Tyson & Blake primarily engages in growth equity investments, which typically involve significant capital to support scaling operations.
What kind of post-investment support does Tyson & Blake provide?
Tyson & Blake offers extensive post-investment support, including strategic advisory services, operational guidance, and assistance with future funding rounds. Their approach is designed to ensure that portfolio companies achieve sustainable growth and operational excellence.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.